Oridonin inhibits pancreatic cancer cell migration and epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling pathway

Paeoniflorin prevents hypoxia-induced epithelial–mesenchymal transition in human breast cancer cells

(2016) Zhenyu Zhou et al.   OncoTargets and Therapy

Asparaginyl endopeptidase promotes the invasion and metastasis of gastric cancer through modulating epithelial-to-mesenchymal transition

(2016) Yuehong Cui et al.   Oncotarget

Oridonin inhibits BxPC-3 cell growth through cell apoptosis

(2015) B. Xu et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects

(2015) Jie Yang et al.   BIOMEDICINE & PHARMACOTHERAPY

The Role of Snail in EMT and Tumorigenesis

(2014) Yifan Wang et al.   CURRENT CANCER DRUG TARGETS

Oridonin suppress cell migration via regulation of nonmuscle myosin IIA

(2014) Yin-Chao Li et al.   CYTOTECHNOLOGY

Oridonin Inhibits Tumor Growth and Metastasis through Anti-Angiogenesis by Blocking the Notch Signaling

(2014) Yanmin Dong et al.   PLoS One

Oridonin Induces Apoptosis, Inhibits Migration and Invasion on Highly-Metastatic Human Breast Cancer Cells

(2013) Shengpeng Wang et al.   AMERICAN JOURNAL OF CHINESE MEDICINE

Oridonin in combination with imatinib exerts synergetic anti-leukemia effect in Ph+ acute lymphoblastic leukemia cells in vitro by inhibiting activation of LYN/mTOR signaling pathway

(2012) Yong Guo et al.   CANCER BIOLOGY & THERAPY

E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma

(2011) K Araki et al.   BRITISH JOURNAL OF CANCER

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc

(2010) Feng-Hou Gao et al.   BMC CANCER

Prognostic Significance of Tumorigenic Cells With Mesenchymal Features in Pancreatic Adenocarcinoma

(2010) Zeshaan A. Rasheed et al.   JNCI-Journal of the National Cancer Institute

Oridonin induces G2/M arrest and apoptosis via activating ERK–p53 apoptotic pathway and inhibiting PTK–Ras–Raf–JNK survival pathway in murine fibrosarcoma L929 cells

(2009) Yan Cheng et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Epithelial-Mesenchymal Transitions in Development and Disease

(2009) Jean Paul Thiery et al.   CELL

SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer

(2009) A. Blackford et al.   CLINICAL CANCER RESEARCH

Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma

(2009) Muh-Hwa Yang et al.   HEPATOLOGY

EMT: When epithelial cells decide to become mesenchymal-like cells

(2009) Raghu Kalluri   JOURNAL OF CLINICAL INVESTIGATION

The basics of epithelial-mesenchymal transition

(2009) Raghu Kalluri et al.   JOURNAL OF CLINICAL INVESTIGATION

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

p38 mitogen-activated protein kinase regulates canonical Wnt- -catenin signaling by inactivation of GSK3 

(2008) R. K. Bikkavilli et al.   JOURNAL OF CELL SCIENCE

Reactive Oxygen Species Mediate Oridonin-Induced HepG2 Apoptosis Through p53, MAPK, and Mitochondrial Signaling Pathways

(2008) Jian Huang et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES